Event chart AKERO THERAPEUTICS, INC. |
|
|
Upcoming events on AKERO THERAPEUTICS, INC. |
|
05/17/23 | | Q1 2023 Earnings Release (Projected) |
11/15/23 | | Q3 2023 Earnings Release (Projected) |
03/14/24 | | FY 2023 Earnings Release (Projected) |
05/15/24 | | Q1 2024 Earnings Release (Projected) |
|
Past events on AKERO THERAPEUTICS, INC. |
|
03/17/23 | 07:00am | | FY 2022 Earnings Release |
01/10/23 | 02:30pm | | JP Morgan Healthcare Conference |
11/29/22 | 01:10pm | | Evercore ISI HealthCONx Conference |
11/17/22 | 04:00am | | Jefferies London Healthcare Conference |
11/07/22 | 03:00pm | | American Association for the Study of Liver Diseases Meeting - Abstract No. 5006 |
11/07/22 | 02:00pm | | American Association for the Study of Liver Diseases Meeting - Abstract No. 5051 |
11/04/22 | 07:00am | | Q3 2022 Earnings Release |
10/17/22 | 01:00pm | | Wainwright Nash Virtual Investor Conference |
09/13/22 | 09:00am | | HARMONY Phase 2b Trial Results Call |
06/16/22 | 08:00pm | | Tissue Fibrosis and Repair Mechanisms, Human Disease and Therapies Symposium - Tim Rolph |
|
Past dividends on AKERO THERAPEUTICS, INC. |
|
- No events available -
|
|
Fiscal Period : December | 2019 | 2020 | 2021 | 2022 | 2023 |
Operating income (EBITDA) M $ |
Released Forecast Spread | -45,7 -44,7 -2,1% | -74,1 -67,6 -9,6% | -101 -97,0 -4,0% | -115 -123 6,4% | -141 |
Operating profit (EBIT) M $ |
Released Forecast Spread | -45,7 -45,0 -1,3% | -80,2 -70,2 -14% | -101 -96,9 -4,1% | -115 -125 8,1% | -139 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -43,8 -45,1 3,0% | -79,2 -69,2 -14% | -101 -96,8 -4,1% | -112 -125 10% | -144 |
Net income M $ |
Released Forecast Spread | -43,8 -45,6 4,1% | -79,2 -68,6 -15% | -101 -96,5 -4,5% | -112 -125 10% | -138 |
EPS $ |
Released Forecast Spread | -2,90 -2,83 -2,4% | -2,52 -2,20 -14% | -2,89 -2,76 -4,9% | -2,87 -3,22 11% | -2,90 | Announcement Date | 03/16/2020 | 03/16/2021 | 02/25/2022 | 03/17/2023 | - |
|
|
Fiscal Period : December | 2020 Q4 | 2021 Q1 | 2021 Q2 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
Operating income (EBITDA) M $ |
Released Forecast Spread | -27,9 -19,7 -41% | -12,8 -25,7 50% | -26,5 -27,7 4,3% | -21,7 -29,0 25% | -32,4 -28,0 -16% | -26,0 -29,0 10% | -27,6
| -36,1 -32,0 -13% | -25,4 -37,0 31% | -28,0 | -32,0 | -37,0 | -44,0 |
Operating profit (EBIT) M $ |
Released Forecast Spread | -29,8 -19,4 -53% | -15,1 -31,5 52% | -29,0 -23,4 -24% | -24,4 -30,2 19% | -32,4 -28,1 -15% | -26,1 -28,2 7,8% | -27,6 -33,8 18% | -36,1 -30,4 -19% | -25,4 -35,9 29% | -30,5 | -36,0 | -34,1 | -40,3 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -29,7 -20,0 -49% | -15,1 -27,9 46% | -28,9 -24,4 -19% | -24,3 -31,4 22% | -32,4 -28,5 -14% | -26,0 -29,3 11% | -27,4 -33,8 19% | -35,5 -30,8 -15% | -23,1 -36,0 36% | -31,0 | -37,9 | -35,0 | -42,5 |
Net income M $ |
Released Forecast Spread | -29,7 -19,3 -54% | -15,1 -31,2 52% | -28,9 -23,1 -25% | -24,3 -30,1 19% | -32,4 -28,1 -15% | -26,0 -28,2 7,8% | -27,4 -33,8 19% | -35,5 -30,3 -17% | -23,1 -35,6 35% | -30,3 | -35,8 | -33,9 | -40,0 |
EPS $ |
Released Forecast Spread | -0,86 -0,57 -51% | -0,43 -0,89 52% | -0,83 -0,66 -25% | -0,70 -0,86 19% | -0,93 -0,80 -16% | -0,74 -0,81 8,5% | -0,77 -0,90 15% | -0,92 -0,72 -28% | -0,49 -0,80 38% | -0,70 | -0,76 | -0,71 | -0,83 | Announcement Date | 03/16/2021 | 05/13/2021 | 08/13/2021 | 11/12/2021 | 02/25/2022 | 05/06/2022 | 08/05/2022 | 11/04/2022 | 03/17/2023 | - | - | - | - | |
|
|
Upcoming sector events for AKERO THERAPEUTICS, INC. |
|
|
|
Past sector events for AKERO THERAPEUTICS, INC. |
|
|
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|